Filter
2097
Text search:
controlled
drugs
Featured
Recommendations
245
New Publications
451
Language
Document type
No document type
1200
Guidelines
388
Studies & Reports
285
Manuals
118
Strategic & Response Plan
45
Fact sheets
24
Training Material
23
Situation Updates
6
Brochures
4
Resource Platforms
2
Infographics
2
Countries / Regions
India
136
Global
64
Kenya
55
South Africa
55
Uganda
41
Western and Central Europe
41
Ethiopia
36
Nigeria
34
Tanzania
33
Africa
30
Latin America and the Carribbean
29
Sierra Leone
28
Nepal
28
Malawi
28
Ukraine
27
Zambia
26
Eastern Europe
25
Philippines
22
Rwanda
22
Ghana
20
Liberia
19
Bangladesh
18
Myanmar / Burma
18
Zimbabwe
17
Russia
17
Syria
15
Indonesia
15
Asia
13
Lesotho
12
South–East Asia Region
12
South Sudan
11
Namibia
11
Eswatini/ Swaziland
11
Brazil
11
Mozambique
10
Colombia
9
Burkina Faso
8
Botswana
8
Congo, Democratic Republic of
7
Germany
7
East and Southern Africa
7
Venezuela
7
Guinea
6
Cameroon
6
Afghanistan
6
Yemen
6
Haiti
5
Lebanon
5
Thailand
5
Sudan
5
Tajikistan
5
Senegal
4
Jordan
4
West and Central Africa
4
Eastern Europe and Central Asia
4
North America
4
Mali
3
USA
3
Pakistan
3
Iraq
3
Cambodia
3
Central African Republic
3
Argentina
3
Angola
3
Madagascar
3
Middle East and North Africa
3
Paraguay
3
Iran
3
Georgia
3
Guinea-Bissau
2
Morocco
2
Saudi Arabia
2
Somalia
2
Egypt
2
China
2
North Macedonia
2
Hungary
2
Ecuador
2
Libya
2
Mexico
2
Sri Lanka
2
Palestine
2
Albania
2
Canada
2
Lithuania
2
Kyrgyzstan
2
Vietnam
2
Jamaica
2
Côte d’Ivoire / Ivory Coast
1
Turkey
1
Singapore
1
Papua New Guinea
1
Benin
1
Peru
1
Serbia
1
Burundi
1
Bolivia
1
Greece
1
Chile
1
Western Pacific Region
1
Bhutan
1
Poland
1
Djibouti
1
Armenia
1
Laos
1
Qatar
1
Moldova
1
Australia
1
Kazakhstan
1
Gabon
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
689
Clinical Guidelines
287
Public Health
122
Women & Child Health
102
Key Resources
59
Pharmacy & Technologies
27
Capacity Building
22
Toolboxes
Mental Health
289
HIV
221
TB
173
COVID-19
97
NTDs
84
Pharmacy
81
NCDs
80
AMR
67
Caregiver
55
Ebola & Marburg
38
Malaria
37
Conflict
33
Refugee
25
Disability
22
Rapid Response
17
Planetary Health
17
Cholera
14
Global Health Education
14
Natural Hazards
12
Polio
7
Health Financing Toolbox
7
Zika
6
Specific Hazards
6
2.0 Rapid Response
3
Social Ethics
2
arrow country studies
Political developments in Myanmar/Burma prompted the Asian-Pacific Resource and Research Centre for Women (ARROW) in 2013 to undertake a small-scale scoping study to re-evaluate and refine its advocacy strategies for sexual and reproductive health and rights (SRHR), and to s ...
Political developments in Myanmar/Burma prompted the Asian-Pacific Resource and Research Centre for Women (ARROW) in 2013 to undertake a small-scale scoping study to re-evaluate and refine its advocacy strategies for sexual and reproductive health and rights (SRHR), and to s ...
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
The pandemic presents tough choices for governments, local communities, health and school systems, as well as families and businesses: How to re-open safely? How to safeguard people’s lives and protect their livelihoods? Where to allocate scarce resources? How to protect those unable to protect th
...
WHO mhGAP Guideline update
recommended
Update of the Mental Health Gap Action Programme
(mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
Cureus 16(2): e53933. DOI 10.7759/cureus.53933
HIV & AIDS Treatment in Practice
Issue 203
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Towards the Peoples Health Assembly Book - 5
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
This summary brief highlights key messages from the updated World Health Organization’s recommendation on tranexamic acid (TXA) for the treatment of postpartum haemorrhage (PPH), including policy and program implications for translating the TXA recommendation into action at the country level. In 2
...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Inequality of access to palliative care and symptom relief is one of the greatest disparities in global health care (1). Currently, there is avoidable suffering on a massive scale due to lack of access to palliative care and symptom relief in low- and middle-income countries (LMICs) (1). Yet basic p
...
The Interagency Emergency Health Kit 2017
recommended
Interagency Guidelines; Medicines and medical devices for 10 000 people for approximately three month.
The power of the Global Drug Policy Index lies in its key objective: to score and
rank how countries are faring in different areas of drug policy as identified in the
UN report ‘What we have learned over the last ten years: A summary of knowledge
acquired and produced by the UN system on drug-r
...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
This guide provides an overview of important points to consider in the assessment and treatment of PTSD and ASD in children and adolescents. The practitioner checklist later in this document can help
to guide assessment and treatment planning.